Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06204354
NCT06204354
Not yet recruiting
Not Applicable

Construction of Gynecological Tumor Sample Library

Peking Union Medical College Hospital0 sites2,500 target enrollmentJanuary 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGynecologic Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gynecologic Cancer
Sponsor
Peking Union Medical College Hospital
Enrollment
2500
Primary Endpoint
construction of Biobank
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Constructing a gynecological tumor samples library, which is open and can be accessed.

Detailed Description

This project is the construction and maintenance of a gynecological tumor sample library. It is supported by the National Key Laboratory of Difficult, Severe, and Rare Diseases at Peking Union Medical College Hospital of the Chinese Academy of Medical Sciences. This project will lay a clinical specimen foundation for exploring the molecular mechanisms of gynecological tumors in the future.

Registry
clinicaltrials.gov
Start Date
January 2024
End Date
January 2027
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •An informed consent form was obtained. If the age is less than 18 years old, the consent form should be signed by the guardian.
  • •Preoperative tumor burden assessment and intraoperative evaluation by the supervising physician (professor) suggest sampling is acceptable.
  • •The research team believes that sampling is possible.
  • •Having the relevant requirements for sample library storage.
  • •Surgical treatment is performed at Peking Union Medical College Hospital.

Exclusion Criteria

  • •Not meeting all inclusion criteria.
  • •The research team considers any circumstances or considerations that may hinder normal pathological evaluation.

Outcomes

Primary Outcomes

construction of Biobank

Time Frame: 3 years

Biobank including gynecolgic cancer samples, including cervical cancer, endometrial cancer, ovarian cancer, vulva cancer, vaginal cancer, and others types

Secondary Outcomes

  • Exploring the molecular mechanism based on biobank(3 year)
  • Drug sensitivity detection based on biobank(3 year)

Similar Trials

Not yet recruiting
Not Applicable
Construction of Gynecological Tumor OrganoidsGynecologic CancerOrganoid
NCT06155370Peking Union Medical College Hospital200
Unknown
Not Applicable
Tissue Bank of Biological Specimens From Patients With Gynecologic DiseaseEndometrial NeoplasmsUterine Cervical NeoplasmsOvarian NeoplasmsLeiomyoma
NCT00299481U.S. Army Medical Research and Development Command7,000
Completed
Not Applicable
Collecting Tumor Samples From Patients With Gynecological TumorsBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedChildhood Embryonal RhabdomyosarcomaChildhood Malignant Ovarian Germ Cell TumorEndometrioid Stromal SarcomaGestational Trophoblastic TumorMalignant MesotheliomaMalignant Ovarian Epithelial TumorMelanomaNeoplasm of Uncertain Malignant PotentialOvarian Brenner TumorOvarian Clear Cell CystadenocarcinomaOvarian Serous CystadenocarcinomaPaget Disease of the VulvaRecurrent Cervical CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Ovarian Germ Cell TumorRecurrent Primary Peritoneal CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Vaginal CarcinomaRecurrent Vulvar CarcinomaStage I Ovarian CancerStage I Uterine Corpus CancerStage I Vaginal CancerStage I Vulvar CancerStage IA Cervical CancerStage IA Fallopian Tube CancerStage IA Ovarian CancerStage IA Ovarian Germ Cell TumorStage IB Cervical CancerStage IB Fallopian Tube CancerStage IB Ovarian CancerStage IB Ovarian Germ Cell TumorStage IC Fallopian Tube CancerStage IC Ovarian CancerStage IC Ovarian Germ Cell TumorStage II Ovarian CancerStage II Uterine Corpus CancerStage II Vaginal CancerStage II Vulvar CancerStage IIA Cervical CancerStage IIA Fallopian Tube CancerStage IIA Ovarian CancerStage IIA Ovarian Germ Cell TumorStage IIB Cervical CancerStage IIB Fallopian Tube CancerStage IIB Ovarian CancerStage IIB Ovarian Germ Cell TumorStage IIC Fallopian Tube CancerStage IIC Ovarian CancerStage IIC Ovarian Germ Cell TumorStage III Borderline Ovarian Surface Epithelial-Stromal TumorStage III Cervical CancerStage III Uterine Corpus CancerStage III Vaginal CancerStage III Vulvar CancerStage IIIA Fallopian Tube CancerStage IIIA Ovarian CancerStage IIIA Ovarian Germ Cell TumorStage IIIA Primary Peritoneal CancerStage IIIB Fallopian Tube CancerStage IIIB Ovarian CancerStage IIIB Ovarian Germ Cell TumorStage IIIB Primary Peritoneal CancerStage IIIC Fallopian Tube CancerStage IIIC Ovarian CancerStage IIIC Ovarian Germ Cell TumorStage IIIC Primary Peritoneal CancerStage IV Borderline Ovarian Surface Epithelial-Stromal TumorStage IV Fallopian Tube CancerStage IV Ovarian CancerStage IV Primary Peritoneal CancerStage IV Uterine Corpus CancerStage IVA Cervical CancerStage IVA Vaginal CancerStage IVB Cervical CancerStage IVB Vaginal CancerStage IVB Vulvar CancerUterine Corpus CancerUterine Corpus LeiomyosarcomaVulvar Squamous Cell Carcinoma
NCT00897442Gynecologic Oncology Group275
Completed
Not Applicable
Pre-Clinical Models in Gynecological Tumors A Tissue RepositoryEndometrial NeoplasmsUterine Neoplasms
NCT00250783University of New Mexico26
Recruiting
Not Applicable
Establishment of a Tumor Bank for Tissue SamplesOvarian NeoplasmsBreast NeoplasmsColorectal NeoplasmsNeoplasms of the Female GenitaliaLung NeoplasmsEndocrine Gland Neoplasms
NCT01789229Medical University of Vienna10,000